Talking it out: new group therapy aims to ease diabetes distress in young adults

NCT ID NCT06936280

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a group-based psychological program called ACTnow for emerging adults (ages 18-35) with type 1 diabetes who feel overwhelmed by their condition. The program includes six bi-weekly sessions led by a psychologist and nurse, focusing on mindfulness and acceptance strategies. Researchers will compare the group therapy to a waitlist to see if it reduces diabetes distress and improves blood sugar levels and overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
group-based psychological intervention (ACTnow) based on Acceptance and Commitment Therapy
What this could lead to
If it works, this could provide an effective, scalable way to reduce diabetes distress and improve quality of life for young adults with type 1 diabetes.
What could go wrong
This is a relatively small trial (100 participants) and the control group will receive the intervention later, so long-term benefits are unclear. The intervention is behavioral, so results depend on participant engagement and may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES DISTRESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Esbjerg Hospital

    RECRUITING

    Esbjerg, Denmark

  • Odense University Hospital

    RECRUITING

    Odense, Denmark

  • Sønderborg Hospital

    RECRUITING

    Sønderborg, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.